Screener
Vir Biotechnology, Inc. VIR PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 573,739 | 514,080 |
| Intangible assets, net | 7,702 | 7,850 |
| Goodwill | 16,937 | 16,937 |
| Property and equipment, net | 50,430 | 55,620 |
| Operating right-of-use assets | 59,391 | 62,099 |
| Restricted cash and cash equivalents, noncurrent | 6,944 | 6,963 |
| Long-term investments | 475,016 | 314,575 |
| Other assets | 24,647 | 24,699 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s PP&E (net)?
- Vir Biotechnology, Inc. (VIR) reported PP&E (net) of $50.43M in Q2 2026.
- How has Vir Biotechnology, Inc.'s PP&E (net) changed year-over-year?
- Vir Biotechnology, Inc.'s PP&E (net) decreased by 17.0% year-over-year, from $60.8M to $50.43M.
- What is the long-term trend for Vir Biotechnology, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s PP&E (net) has grown at a 25.4% compound annual growth rate (CAGR), from $17.95M to $55.62M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Vir Biotechnology, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude